Search

everythinglearnresearchcommunity

for

Search:↓

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Oral dutasteride is a recommended first treatment for frontal fibrosing alopecia.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Finasteride causes lasting fertility decrease in rats.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Testosterone reduces heart damage and inflammation after injury.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Finasteride impairs sperm quality and fertility in rats, even after stopping treatment.

Canadian lawsuits involving 5-alpha-reductase inhibitors are related to persistent erectile dysfunction side effects, with no judgments against companies yet.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Finasteride reduces pain in male rats and works better with testosterone.

Researchers developed a quick and accurate method to measure finasteride and tamsulosin in tablets.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.